Cell Manufacturing Topic: Resolving process variability as the primary barrier to scalable cell therapy manufacturing
04 May 2026
Next Gen Vector Engineering & Delivery
- What are the primary sources of process variability across cell expansion, transduction, and fill finish, and how can they be systematically reduced?
- How can we improve process robustness while maintaining cell potency, viability, and phenotype consistency?
- Where do current control strategies fail during tech transfer from development to GMP manufacturing?
- What advanced in process analytics are needed to enable real time monitoring and tighter process control?
- How can closed and automated systems reduce operator dependent variability without compromising flexibility?
Industry Expert
